Seattle, WashingtonCertified Nursing Asst. - 0.6 FTE - Infusion Services
Seattle, WashingtonTeam Coordinator
Seattle, WashingtonTeam Coordinator
Seattle, WashingtonClinical Care Coordinator (MA or LPN)
Seattle Cancer Care Alliance
The Seattle Cancer Care Alliance was incorporated in 1998 as a separate, jointly governed non-profit that included the cancer programs of three partners. Seattle Cancer Care Alliance is a cancer treatment center that unites doctors from Fred Hutchison Cancer Research Center, University of Washington Medical Center, and Seattle Children’s. The purpose of this organization is to provide state-of the-art patient and family centered care; support the conduct of cancer clinical research and education; enhance access to improved cancer interventions; and advance the standard of cancer care regionally and beyond. The Seattle Cancer Care Alliance is the only NCI-designated comprehensive cancer center in the Northwest, and according to the National Cancer Data Base, Seattle Cancer Care Alliance patients in general have better survival rates than patients treated at other cancer treatment center.
Medical and Vision Insurance
SCCA employees may choose between a preferred-provider plan (Premera Blue Cross) and a point-of-service plan (Alliant Plus) for themselves and their families.
SCCA employees may choose between two plans offered through Washington Dental Service (WDS). The WDS network includes approximately 90 percent of the dentists in Washington State.
Flexible Spending Accounts
Employees can save money on eligible health and dependent care expenses through flexible spending accounts; deductions for these accounts are made on a pre-tax basis.
Life/Accidental Death & Dismemberment (AD&D) Insurance
SCCA provides life and AD&D insurance equal to two times annual pay. Additional life insurance can be purchased through the voluntary supplemental plan for employees and dependents.
SCCA pays for short- and long-term disability coverage for employees. This insurance pays a benefit equal to 60 percent of base pay after a 30-day waiting period.
403(b) Retirement Savings Plan
SCCA makes a 7-percent contribution to an employee’s 403(b) plan after one year and 1,000 hours of service. No employee contribution is required to receive this benefit. Employees can participate in the plan immediately, with investment options thru TIAA-CREF and Fidelity Investments.
Employees accrue 12 days of vacation during the first year of employment. Subsequently, they accrue an additional day per year until they reach the maximum accrual of 22 days per year. Accrual rate is pro-rated for part-time employees.
Salary Continuance (Sick Leave)
Employees are eligible for salary continuance after 30 days of employment. Under this plan, employees will accrue eight hours of sick leave per month (pro-rated for part-time) for time off due to illness or injury.
Holidays and Personal Days
Twelve paid holidays; 10 holidays are generally scheduled with the remaining given as personal days.
SCCA provides a subsidized annual transportation pass for use on Metro, Community Transit, Pierce Transit, Sound Transit and Metro vanpools. Reduced parking costs for vanpools and carpools are available.
Staff Events Program
SCCA recognizes that work in the healthcare industry can sometimes be demanding and stressful, especially in a field that requires employees to care for those facing cancer. For this reason, a staff events program was created to provide an outlet for staff to relax, have fun, enjoy quality time with family and friends, and receive items and services for free or at a discounted rate.
Other benefits for employees include the following:
- Voluntary group long-term care insurance
- Employee assistance program
- On-site childcare, and childcare program for sick children
- Health-club discounts to many local gyms
- Semi-monthly paydays
- Watermark Credit Union
- Hometown Home Loan Program through HomeStreet Bank
- Facility amenities, including bike racks, shower rooms, on-site coffee bar and cafeteria
**This information is intended as a summary**
SCCA Purpose & Mission
Seattle Cancer Care Alliance (SCCA) unites the doctors from Fred Hutchinson Cancer Research Center, UW Medicine, and Seattle Children’s into one world-class treatment center. SCCA was incorporated in 1998 as a separate, jointly governed non-profit that includes the cancer programs of the three partners. Each partner has equal ownership of SCCA. Dr. Fred Appelbaum is the Executive Director of SCCA.
- Provide state-of-the-art, patient and family centered care.
- Support the conduct of cancer clinical research and education.
- Enhance access to improved cancer interventions, and advance the standard of cancer care regionally and beyond.
Lead the world in translating scientific discovery into the prevention, diagnosis, treatment, and cure of cancer.
In 2011 over 300 oncologists, surgeons, radiologists, pathologists, and research physicians treated over 5,500 patients for many types of cancers including leukemia, lymphoma, breast, prostate, lung, and colon cancer. SCCA patients have access to the latest cancer treatments including stem cell and bone marrow transplantation, gene therapy, specialized antibody therapies, high-dose chemotherapy, radiation therapy, immunotherapy, minimally invasive surgical techniques, and other specialized therapies. Patients receive their outpatient care at the SCCA clinic on Lake Union. Inpatient care is provided at UW Medical Center and Seattle Children’s.
Last year the Fred Hutchinson Bone Marrow Transplant Program at SCCA performed over 500 bone marrow transplants. In 2008, the program was ranked first in outcomes in a five-year study by the National Bone Marrow Donor Program that measured one-year survival rates of patients among 122 transplant centers in the United States.
A major focus of SCCA is to speed up the transfer of new diagnostic and treatment techniques from the research setting to patient care. The highly integrated approach to cancer research and treatment among SCCA partner organizations supports the flow of scientific information among researchers, clinicians, and patients, thereby accelerating the development of new knowledge and treatment of various cancers and blood disorders.